Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

URMEEL HASMUKH PATEL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1013263110
CMS profile
534521
Location
SHENANDOAH, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$3,616.69

189 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,402.06 184
Education $214.63 5

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $340.26 15
Janssen Biotech, Inc. $264.75 16
Seagen Inc. $202.07 8
AstraZeneca Pharmaceuticals LP $194.28 12
GENZYME CORPORATION $193.82 9
GlaxoSmithKline, LLC. $193.49 8
Incyte Corporation $177.14 10
Novartis Pharmaceuticals Corporation $174.71 11
Daiichi Sankyo Inc. $156.00 7
Bayer HealthCare Pharmaceuticals Inc. $113.33 6
E.R. Squibb & Sons, L.L.C. $103.03 6
Merck Sharp & Dohme Corporation $97.62 5
Astellas Pharma US Inc $96.55 6
Celgene Corporation $96.38 5
Takeda Pharmaceuticals U.S.A., Inc. $84.80 3
Lilly USA, LLC $73.11 4
Gilead Sciences, Inc. $67.43 4
Ipsen Biopharmaceuticals, Inc $66.32 3
BeiGene USA, Inc. $57.87 3
Dova Pharmaceuticals $54.60 3
Taiho Oncology, Inc. $54.13 3
Boehringer Ingelheim Pharmaceuticals, Inc. $54.03 4
Myovant Sciences Inc. $50.22 2
PFIZER INC. $43.19 2
Myriad Genetic Laboratories, Inc. $38.75 2
Eisai Inc. $37.75 2
Janssen Pharmaceuticals, Inc $33.73 2
Acrotech Biopharma LLC $33.71 2
Pharmacosmos Therapeutics Inc. $33.56 2
AMAG Pharmaceuticals, Inc. $31.75 2
Regeneron Healthcare Solutions, Inc. $31.37 2
MorphoSys, US Inc. $31.00 2
Alexion Pharmaceuticals, Inc. $29.15 2
Blue Earth Diagnostics Limited $27.06 1
TOLMAR Pharmaceuticals, Inc. $25.14 1
Deciphera Pharmaceuticals Inc. $23.53 1
Genentech USA, Inc. $22.47 1
JAZZ PHARMACEUTICALS INC. $22.27 1
AbbVie Inc. $22.17 1
Nestle HealthCare Nutrition Inc. $21.21 1
Pharmacyclics LLC, An AbbVie Company $20.17 1
Servier Pharmaceuticals LLC $18.63 1
Rigel Pharmaceuticals, Inc. $18.23 1
Karyopharm Therapeutics Inc. $15.76 1
Aveo Pharmaceuticals, Inc. $15.28 1
Alnylam Pharmaceuticals Inc. $14.49 1
Adaptive Biotechnologies Corporation $14.12 1
Epizyme, Inc., $13.88 1
Exelixis Inc. $12.38 1

Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

URMEEL HASMUKH PATEL

NPI 1013263110 · CMS profile ID 534521

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

SHENANDOAH, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1013263110?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
URMEEL HASMUKH PATEL, NPI 1013263110, CMS profile ID 534521. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1013263110?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). URMEEL HASMUKH PATEL, NPI 1013263110, CMS profile ID 534521. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1013263110?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
URMEEL HASMUKH PATEL, NPI 1013263110, CMS profile ID 534521, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 189 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1013263110?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

189 matching records · $3,616.69 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 189 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 189.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $33.8907/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820138789 CMS
Amgen Inc. $23.3707/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826450109 CMS
Daiichi Sankyo Inc. $17.5807/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836307845 CMS
Seagen Inc. $24.8607/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832162811 CMS
AstraZeneca Pharmaceuticals LP $17.7607/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830049315 CMS
AMAG Pharmaceuticals, Inc. $12.8307/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 847687037 CMS
Incyte Corporation $8.8207/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835568049 CMS
GENZYME CORPORATION $22.6207/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843715117 CMS
Ipsen Biopharmaceuticals, Inc $19.8607/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841902595 CMS
Merck Sharp & Dohme Corporation $18.0006/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848534397 CMS
Bayer HealthCare Pharmaceuticals Inc. $20.2706/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789177359 CMS
BeiGene USA, Inc. $21.0206/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846700479 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.6606/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763755274 CMS
E.R. Squibb & Sons, L.L.C. $22.2106/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783571949 CMS
E.R. Squibb & Sons, L.L.C. $18.3606/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783571969 CMS
Dova Pharmaceuticals $21.6106/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849749271 CMS
Seagen Inc. $74.9906/22/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832162799 CMS
Daiichi Sankyo Inc. $21.6306/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836300129 CMS
Nestle HealthCare Nutrition Inc. $21.2106/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820941067 CMS
Novartis Pharmaceuticals Corporation $15.7906/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813152307 CMS
Seagen Inc. $16.6706/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832162815 CMS
Ipsen Biopharmaceuticals, Inc $26.8706/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841903221 CMS
AstraZeneca Pharmaceuticals LP $18.4006/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829315839 CMS
Janssen Biotech, Inc. $15.9506/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788934089 CMS
Janssen Biotech, Inc. $6.6106/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788934091 CMS
Seagen Inc. $14.2106/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832162787 CMS
Astellas Pharma US Inc $14.0706/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821487569 CMS
Celgene Corporation $16.7206/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783710349 CMS
Gilead Sciences, Inc. $11.9206/01/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845877725 CMS
GlaxoSmithKline, LLC. $15.8805/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802811095 CMS
Myriad Genetic Laboratories, Inc. $17.9705/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834568981 CMS
BeiGene USA, Inc. $15.8005/21/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846700473 CMS
Merck Sharp & Dohme Corporation $14.4405/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848517495 CMS
Incyte Corporation $22.4705/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835568029 CMS
Pharmacyclics LLC, An AbbVie Company $20.1705/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781013857 CMS
Bayer HealthCare Pharmaceuticals Inc. $20.0505/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789085905 CMS
Lilly USA, LLC $22.4305/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818819839 CMS
Blue Earth Diagnostics Limited $27.0605/13/2021 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 844631315 CMS
Daiichi Sankyo Inc. $21.3505/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836290043 CMS
Celgene Corporation $17.8505/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783710347 CMS
Novartis Pharmaceuticals Corporation $17.9605/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813152303 CMS
Astellas Pharma US Inc $11.0705/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821487563 CMS
Deciphera Pharmaceuticals Inc. $23.5304/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826797071 CMS
GENZYME CORPORATION $18.7104/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843715095 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.9304/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763755276 CMS
AstraZeneca Pharmaceuticals LP $5.8404/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829508515 CMS
Servier Pharmaceuticals LLC $18.6304/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852924383 CMS
Bayer HealthCare Pharmaceuticals Inc. $19.6104/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789078813 CMS
Merck Sharp & Dohme Corporation $23.7004/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848389355 CMS
Alexion Pharmaceuticals, Inc. $12.7804/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783124479 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,989.58 78
PY2020 $1,635.84 91
PY2021 $3,616.69 189
PY2022 $4,947.32 249
PY2023 $18,956.92 334
PY2024 $20,409.47 292
PY2025 $13,641.48 247

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $35,797.59 2
PY2024 Principal investigator $76,129.42 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $1,107.99 08/31/2025 Non-covered Recipient Entity
Millennium Research & Clinical Development
A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants with EGFR-mutated, Advanced Non-squamous Non-small Cell Lung Cancer NSCLC Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors No dispute reported 06/30/2026 1232923542
Principal investigator 1 Merck Sharp & Dohme LLC $34,689.60 08/31/2025 Non-covered Recipient Entity
Millennium Research & Clinical Development
A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB N2 NSCLC not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Follow No dispute reported 06/30/2026 1232924254